Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-24T16:52:05.663Z Has data issue: false hasContentIssue false
  • English
  • Français

Hyperuricaemia in congenital heart disease patients

Published online by Cambridge University Press:  24 September 2013

Efrén Martínez-Quintana  and
Fayna Rodríguez-González
Efrén Martínez-Quintana*
Affiliation:
Cardiology Service, Insular-Materno Infantil University Hospital, Las Palmas de Gran Canaria, Spain
Fayna Rodríguez-González
Affiliation:
Dr. Negrín University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Spain
*
Correspondence to: Dr E. Martínez Quintana, Complejo Universitario Insular-Materno Infantil. Avenida Marítima del Sur s/n. 35016. Las Palmas de Gran Canaria, Spain. Tel: +0034 928441360; Fax: +0034 928441853; E-mail: efrencardio@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Introductio

Hyperuricaemia is associated with traditional cardiovascular risk factors such as type 2 diabetes or dyslipidaemia and a higher mortality.

Methods

Out of 528 congenital heart disease patients, 329 patients, including 190 male and 139 female patients, in whom uric acid determination was performed, were studied and followed up to determine survival.

Results

Male congenital heart disease patients with high serum uric acid concentrations (>7 mg/dl) showed significantly (p < 0.05) higher body mass index, serum creatinine, total cholesterol, low-density lipoprotein-cholesterol, triglycerides, and C-reactive protein concentrations than those male congenital heart disease patients with lower serum uric acid levels (≤7 mg/dl). Meanwhile, female congenital heart disease patients with higher serum uric acid concentrations (>5.7 mg/dl) were significantly (p < 0.05) younger, more hypoxaemic, more obese, and with higher C-reactive protein and N-terminal-pro-B-type natriuretic peptide levels than those female congenital heart disease patients with lower serum uric acid concentrations (≤5.7 mg/dl). During a median follow-up of 90 months, 16 out of 528 congenital heart disease patients died – 14 patients of cardiac origin and two patients of non-cardiac origin – of whom 10 were hypoxaemic. Kaplan–Meier analysis showed no significant differences in mortality between male and female congenital heart disease patients with high and low serum uric acid level concentrations.

Conclusions

Hypoxaemia, body mass index, and C-reactive protein concentrations are higher in hyperuricaemic congenital heart disease patients, although no significant differences were seen in mortality between congenital heart disease patients with high and low serum uric acid concentrations.

Keywords

Hyperuricaemiaserum uric acidcongenitalsurvival
Type
Original Articles
Information
Cardiology in the Young , Volume 25 , Issue 1 , January 2015 , pp. 29 - 34
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Rho, YH, Zhu, Y, Choi, HK. The epidemiology of uric acid and fructose. Semin Nephrol 2011; 31: 410–419.CrossRefGoogle ScholarPubMed
2. Ford, ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769–1778.CrossRefGoogle ScholarPubMed
3. Viazzi, F, Leoncini, G, Ratto, E, et al. Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived. J Clin Hypertens 2006; 8: 510–518.CrossRefGoogle ScholarPubMed
4. Centers for Disease Control and Prevention. NHANES-III 1988–94 Reference Manuals Reports (on CD-ROM). National Center for Health Statistics, Hyattsville, MD, 1996.Google Scholar
5. Nicholls, A, Snaith, ML, Scott, JT. Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J 1973; 1: 449–451.CrossRefGoogle Scholar
6. Gao, X, Qi, L, Qiao, N, et al. Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension 2007; 50: 306–312.CrossRefGoogle ScholarPubMed
7. Fox, IH, Kelley, WN. Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism 1972; 21: 713–721.CrossRefGoogle ScholarPubMed
8. Cohen, E, Krause, I, Fraser, A, et al. Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel. Isr Med Assoc J 2012; 14: 676–680.Google ScholarPubMed
9. Ford, ES, Li, C, Cook, S, et al. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007; 115: 2526–2532.CrossRefGoogle ScholarPubMed
10. Invitti, C, Maffeis, C, Gilardini, L, et al. Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes 2006; 30: 627–633.CrossRefGoogle ScholarPubMed
11. Feig, DI, Kang, DH, Johnson, RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811–1821.CrossRefGoogle ScholarPubMed
12. Ho, WJ, Tsai, WP, Yu, KH, et al. Association between endothelial dysfunction and hyperuricaemia. Rheumatology 2010; 49: 1929–1934.CrossRefGoogle ScholarPubMed
13. Hayabuchi, Y, Matsuoka, S, Akita, H, et al. Hyperuricaemia in cyanotic congenital heart disease. Eur J Pediatr 1993; 152: 873–876.CrossRefGoogle ScholarPubMed
14. Martínez-Quintana, E, Rodríguez-González, F, Fábregas-Brouard, M, et al. Serum and 24-hour urine analysis in adult cyanotic and noncyanotic congenital heart disease patients. Congenit Heart Dis 2009; 4: 147–152.CrossRefGoogle ScholarPubMed
15. Ruggiero, C, Cherubini, A, Ble, A, et al. Uric acid and inflammatory markers. Eur Heart J 2006; 27: 1174–1181.CrossRefGoogle ScholarPubMed
16. Nakagawa, T, Kang, DH, Feig, D, et al. Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int 2006; 69: 1722–1725.CrossRefGoogle ScholarPubMed
17. Kang, DH, Park, SK, Lee, IK, et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16: 3553–3562.CrossRefGoogle ScholarPubMed
18. Libby, P, Ridker, PM, Maseri, A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135–1143.CrossRefGoogle ScholarPubMed
19. Strasak, A, Ruttmann, E, Brant, L, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem 2008; 54: 273–284.CrossRefGoogle Scholar
20. Strasak, AM, Kelleher, CC, Brant, LJ, et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol 2008; 125: 232–239.CrossRefGoogle ScholarPubMed
21. Ioachimescu, AG, Brennan, DM, Hoar, BM, et al. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 2008; 58: 623–630.CrossRefGoogle ScholarPubMed
22. Baker, JF, Krishnan, E, Chen, L, et al. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005; 118: 816–826.CrossRefGoogle ScholarPubMed
23. Krishnan, E, Sokolove, J. Uric acid in heart disease: a new C-reactive protein? Curr Opin Rheumatol 2011; 23: 174–177.CrossRefGoogle ScholarPubMed
24. Culleton, BF, Larson, MG, Kannel, WB, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131: 7–13.CrossRefGoogle ScholarPubMed
25. Grassi, D, Ferri, L, Desideri, G, et al. Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr Pharm Des 2013; 19: 2432–2438.CrossRefGoogle ScholarPubMed
26. Kenny, D, Hijazi, ZM. Coarctation of the aorta: from fetal life to adulthood. Cardiol J 2011; 18: 487–495.CrossRefGoogle ScholarPubMed